Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1991 Mar;87(3):859–864. doi: 10.1172/JCI115090

Infantile form of carnitine palmitoyltransferase II deficiency with hepatomuscular symptoms and sudden death. Physiopathological approach to carnitine palmitoyltransferase II deficiencies.

F Demaugre 1, J P Bonnefont 1, M Colonna 1, C Cepanec 1, J P Leroux 1, J M Saudubray 1
PMCID: PMC329874  PMID: 1999498

Abstract

Reported cases of carnitine palmitoyltransferase II (CPT II) deficiency are characterized only by a muscular symptomatology in young adults although the defect is expressed in extra-muscular tissues as well as in skeletal muscle. We describe here a CPT II deficiency associating hypoketotic hypoglycemia, high plasma creatine kinase level, heart beat disorders, and sudden death in a 3-mo-old boy. CPT II defect (-90%) diagnosed in fibroblasts is qualitatively similar to that (-75%) of two "classical" CPT II-deficient patients previously studied: It resulted from a decreased amount of CPT II probably arising from its reduced biosynthesis. Consequences of CPT II deficiency studied in fibroblasts differed in both sets of patients. An impaired oxidation of long-chain fatty acids was found in the proband but not in patients with the "classical" form of the deficiency. The metabolic and clinical consequences of CPT II deficiency might depend, in part, on the magnitude of residual CPT II activity. With 25% residual activity CPT II would become rate limiting in skeletal muscle but not in liver, heart, and fibroblasts. As observed in the patient described herein, CPT II activity ought to be more reduced to induce an impaired oxidation of long-chain fatty acids in these tissues.

Full text

PDF
859

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bertorini T., Yeh Y. Y., Trevisan C., Stadlan E., Sabesin S., DiMauro S. Carnitine palmityl transferase deficiency: myoglobinuria and respiratory failure. Neurology. 1980 Mar;30(3):263–271. doi: 10.1212/wnl.30.3.263. [DOI] [PubMed] [Google Scholar]
  2. Bieber L. L., Abraham T., Helmrath T. A rapid spectrophotometric assay for carnitine palmitoyltransferase. Anal Biochem. 1972 Dec;50(2):509–518. doi: 10.1016/0003-2697(72)90061-9. [DOI] [PubMed] [Google Scholar]
  3. Bonnefont J. P., Haas R., Wolff J., Thuy L. P., Buchta R., Carroll J. E., Saudubray J. M., Demaugre F., Nyhan W. L. Deficiency of carnitine palmitoyltransferase I. J Child Neurol. 1989 Jul;4(3):198–203. doi: 10.1177/088307388900400310. [DOI] [PubMed] [Google Scholar]
  4. Bougnères P. F., Saudubray J. M., Marsac C., Bernard O., Odièvre M., Girard J. Fasting hypoglycemia resulting from hepatic carnitine palmitoyl transferase deficiency. J Pediatr. 1981 May;98(5):742–746. doi: 10.1016/s0022-3476(81)80834-7. [DOI] [PubMed] [Google Scholar]
  5. COOPERSTEIN S. J., LAZAROW A. A microspectrophotometric method for the determination of cytochrome oxidase. J Biol Chem. 1951 Apr;189(2):665–670. [PubMed] [Google Scholar]
  6. Clarke P. R., Bieber L. L. Isolation and purification of mitochondrial carnitine octanoyltransferase activities from beef heart. J Biol Chem. 1981 Oct 10;256(19):9861–9868. [PubMed] [Google Scholar]
  7. Corr P. B., Creer M. H., Yamada K. A., Saffitz J. E., Sobel B. E. Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J Clin Invest. 1989 Mar;83(3):927–936. doi: 10.1172/JCI113978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Declercq P. E., Falck J. R., Kuwajima M., Tyminski H., Foster D. W., McGarry J. D. Characterization of the mitochondrial carnitine palmitoyltransferase enzyme system. I. Use of inhibitors. J Biol Chem. 1987 Jul 15;262(20):9812–9821. [PubMed] [Google Scholar]
  9. Demaugre F., Bonnefont J. P., Cepanec C., Scholte J., Saudubray J. M., Leroux J. P. Immunoquantitative analysis of human carnitine palmitoyltransferase I and II defects. Pediatr Res. 1990 May;27(5):497–500. doi: 10.1203/00006450-199005000-00016. [DOI] [PubMed] [Google Scholar]
  10. Demaugre F., Bonnefont J. P., Mitchell G., Nguyen-Hoang N., Pelet A., Rimoldi M., Di Donato S., Saudubray J. M. Hepatic and muscular presentations of carnitine palmitoyl transferase deficiency: two distinct entities. Pediatr Res. 1988 Sep;24(3):308–311. doi: 10.1203/00006450-198809000-00006. [DOI] [PubMed] [Google Scholar]
  11. Di Donato S., Castiglione A., Rimoldi M., Cornelio F., Vendemia F., Cardace G., Bertagnolio B. Heterogeneity of carnitine-palmitoyltransferase deficiency. J Neurol Sci. 1981 May;50(2):207–215. doi: 10.1016/0022-510x(81)90167-2. [DOI] [PubMed] [Google Scholar]
  12. Farrell S. O., Fiol C. J., Reddy J. K., Bieber L. L. Properties of purified carnitine acyltransferases of mouse liver peroxisomes. J Biol Chem. 1984 Nov 10;259(21):13089–13095. [PubMed] [Google Scholar]
  13. Felig P., Wahren J. Fuel homeostasis in exercise. N Engl J Med. 1975 Nov 20;293(21):1078–1084. doi: 10.1056/NEJM197511202932107. [DOI] [PubMed] [Google Scholar]
  14. Fenton W. A., Hack A. M., Kraus J. P., Rosenberg L. E. Immunochemical studies of fibroblasts from patients with methylmalonyl-CoA mutase apoenzyme deficiency: detection of a mutation interfering with mitochondrial import. Proc Natl Acad Sci U S A. 1987 Mar;84(5):1421–1424. doi: 10.1073/pnas.84.5.1421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fiol C. J., Bieber L. L. Sigmoid kinetics of purified beef heart mitochondrial carnitine palmitoyltransferase. Effect of pH and malonyl-CoA. J Biol Chem. 1984 Nov 10;259(21):13084–13088. [PubMed] [Google Scholar]
  16. Guengerich F. P., Wang P., Davidson N. K. Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Biochemistry. 1982 Mar 30;21(7):1698–1706. doi: 10.1021/bi00536a035. [DOI] [PubMed] [Google Scholar]
  17. Herman J., Nadler H. L. Recurrent myoglobinuria and muscle carnitine palmityltransferase deficiency. J Pediatr. 1977 Aug;91(2):247–250. doi: 10.1016/s0022-3476(77)80821-4. [DOI] [PubMed] [Google Scholar]
  18. Kelly K. J., Garland J. S., Tang T. T., Shug A. L., Chusid M. J. Fatal rhabdomyolysis following influenza infection in a girl with familial carnitine palmityl transferase deficiency. Pediatrics. 1989 Aug;84(2):312–316. [PubMed] [Google Scholar]
  19. Kopec B., Fritz I. B. Comparison of properties of carnitine palmitoyltransferase I with those of carnitine palmitoyltransferase II, and preparation of antibodies to carnitine palmitoyltransferases. J Biol Chem. 1973 Jun 10;248(11):4069–4074. [PubMed] [Google Scholar]
  20. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  21. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  22. Lund H. Carnitine palmitoyltransferase: characterization of a labile detergent-extracted malonyl-CoA-sensitive enzyme from rat liver mitochondria. Biochim Biophys Acta. 1987 Mar 13;918(1):67–75. doi: 10.1016/0005-2760(87)90010-5. [DOI] [PubMed] [Google Scholar]
  23. McGarry J. D., Foster D. W. Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem. 1980;49:395–420. doi: 10.1146/annurev.bi.49.070180.002143. [DOI] [PubMed] [Google Scholar]
  24. McGarry J. D., Leatherman G. F., Foster D. W. Carnitine palmitoyltransferase I. The site of inhibition of hepatic fatty acid oxidation by malonyl-CoA. J Biol Chem. 1978 Jun 25;253(12):4128–4136. [PubMed] [Google Scholar]
  25. McGarry J. D., Woeltje K. F., Schroeder J. G., Cox W. F., Foster D. W. Carnitine palmitoyltransferase--structure/function/regulatory relationships. Prog Clin Biol Res. 1990;321:193–208. [PubMed] [Google Scholar]
  26. Miyazawa S., Ozasa H., Osumi T., Hashimoto T. Purification and properties of carnitine octanoyltransferase and carnitine palmitoyltransferase from rat liver. J Biochem. 1983 Aug;94(2):529–542. doi: 10.1093/oxfordjournals.jbchem.a134384. [DOI] [PubMed] [Google Scholar]
  27. Murthy M. S., Pande S. V. Malonyl-CoA binding site and the overt carnitine palmitoyltransferase activity reside on the opposite sides of the outer mitochondrial membrane. Proc Natl Acad Sci U S A. 1987 Jan;84(2):378–382. doi: 10.1073/pnas.84.2.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Saudubray J. M., Coudé F. X., Demaugre F., Johnson C., Gibson K. M., Nyhan W. L. Oxidation of fatty acids in cultured fibroblasts: a model system for the detection and study of defects in oxidation. Pediatr Res. 1982 Oct;16(10):877–881. doi: 10.1203/00006450-198210000-00015. [DOI] [PubMed] [Google Scholar]
  29. Tein I., Demaugre F., Bonnefont J. P., Saudubray J. M. Normal muscle CPT1 and CPT2 activities in hepatic presentation patients with CPT1 deficiency in fibroblasts. Tissue specific isoforms of CPT1? J Neurol Sci. 1989 Sep;92(2-3):229–245. doi: 10.1016/0022-510x(89)90139-1. [DOI] [PubMed] [Google Scholar]
  30. Weatherill P. J., Kennedy S. M., Burchell B. Immunochemical comparison of UDP-glucuronyltransferase from Gunn- and Wistar-rat livers. Biochem J. 1980 Oct 1;191(1):155–163. doi: 10.1042/bj1910155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Wisneski J. A., Gertz E. W., Neese R. A., Mayr M. Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans. J Clin Invest. 1987 Feb;79(2):359–366. doi: 10.1172/JCI112820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Woeltje K. F., Kuwajima M., Foster D. W., McGarry J. D. Characterization of the mitochondrial carnitine palmitoyltransferase enzyme system. II. Use of detergents and antibodies. J Biol Chem. 1987 Jul 15;262(20):9822–9827. [PubMed] [Google Scholar]
  33. Zammit V. A., Corstorphine C. G., Kelliher M. G. Evidence for distinct functional molecular sizes of carnitine palmitoyltransferases I and II in rat liver mitochondria. Biochem J. 1988 Mar 1;250(2):415–420. doi: 10.1042/bj2500415. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES